Urinary vitamin D-binding protein as a biomarker of steroid-resistant nephrotic syndrome

Biomarker Insights

Volumn 11, Issue , 2016, Pages 1-6

  Bennett, Michael R ^a   Pordal, Angad ^a   Haffner, Christopher ^a   Pleasant, Latawnya ^a   Ma, Qing ^a   Devarajan, Prasad ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Focal segmental glomerulosclerosis; Minimal change disease; Nephrotic syndrome; Steroid resistance; Vitamin D

Indexed keywords

BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; CREATININE; MYCOPHENOLATE MOFETIL; STEROID; VITAMIN D BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL STUDY; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; ELISA KIT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MICROALBUMINURIA; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; STEROID SENSITIVE NEPHROTIC SYNDROME; URINALYSIS;

EID: 84956885978     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/Bmi.s31633     Document Type: Article

References (29)

1. Lewis JB, Nielson EG. Glomerular diseases. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison’s Principles of Internal Medicine. 18th ed. New York, NY: McGraw Hill; 2012:283.
2. Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis. 1998;32(1):72–9.
3. Hari P, Bagga A, Jindal N, et al. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol. 2001;16(11):901–5.
4. Gipson DS, Chin H, Presler TP, et al. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol. 2006;21(3):344–9.
5. Roberti I, Vyas S. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus. Pediatr Nephrol. 2010;25(6):1117–24.
6. Gulati S, Sharma AP, Sharma RK, et al. Changing trends of histopathology in childhood nephrotic syndrome. Am J Kidney Dis. 1999;34(4):646–50.
7. Bonilla-Felix M, Parra C, Dajani T, et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int. 1999;55(5):1885–90.
8. Srivastava T, Simon SD, Alon US. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol. 1999;13(1):13–8.
9. Smith JM, Stablein DM, Munoz R, et al. Contributions of the transplant registry: the 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant. 2007;11(4):366–73.
10. Korbet SM. Clinical picture and outcome of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant. 1999;14(suppl 3):68–73.
11. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362(9384):629–39.
12. Gulati S, Sharma AP, Sharma RK, et al. Do current recommendations for kidney biopsy in nephrotic syndrome need modifications? Pediatr Nephrol. 2002;17(6):404–8.
13. Barragry JM, France MW, Carter ND, et al. Vitamin-D metabolism in nephrotic syndrome. Lancet. 1977;2(8039):629–32.
14. Chesney RW, Hamstra A, Rose P, et al. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis. Int J Pediatr Nephrol. 1984;5(1):1–4.
15. Yousefzadeh P, Shapses SA, Wang X. Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions. Int J Endocrinol. 2014;2014:6.
16. Sato KA, Gray RW, Lemann J Jr. Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med. 1982;99(3):325–30.
17. Vlasova IM, Saletsky AM. Study of the denaturation of human serum albumin by sodium dodecyl sulfate using the intrinsic fluorescence of albumin. J Appl Spectrosc. 2009;76(4):536–41.
18. Tang WX, Bazaraa HM, Magiera H, et al. Electrophoretic mobility shift assay identifies vitamin D binding protein (Gc-globulin) in human, rat, and mouse sera. Anal Biochem. 1996;237(2):245–51.
19. Grymonprez A, Proesmans W, Van Dyck M, et al. Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol. 1995;9(3):278–81.
20. Weng FL, Shults J, Herskovitz RM, et al. Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission. Pediatr Nephrol. 2005;20(1):56–63.
21. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629–37.
22. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):1–266.
23. Doorenbos CR, de Cuba MM, Vogt L, et al. Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease. J Steroid Biochem Mol Biol. 2012;128(12):56–61.
24. Mirkovic K, Doorenbos CR, Dam WA, et al. Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis. PLoS One. 2013;8(2):e55887.
25. Valles P, Peralta M, Carrizo L, et al. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria. Pediatr Nephrol. 2000;15(34):252–8.
26. Bennett MR, Piyaphanee N, Czech K, et al. NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome. Pediatr Nephrol. 2012;27(5):807–12.
27. Woroniecki RP, Shatat IF, Supe K, et al. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood. Am J Nephrol. 2008;28(1):83–90.
28. Woroniecki RP, Orlova TN, Mendelev N, et al. Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Am J Nephrol. 2006;26(3):258–67.
29. Nielsen CA, Jensen JE, Cortes D. Vitamin D status is insufficient in the majority of children at diagnosis of nephrotic syndrome. Danish Med J. 2015;62(2): pii: 5017.